Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “2019-nCoV (COVID-19)”

322 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 322 results

Testing effectiveness (Phase 2)Ended earlyNCT04834908
What this trial is testing

Evaluation of Equine Antibody Treatment in Patients With COVID 19 Infection

Who this might be right for
SARS-CoV-2 Infection
Bharat Serums and Vaccines Limited 7
Not applicableStudy completedNCT04371432
What this trial is testing

Genetics of COVID-19 Susceptibility and Manifestations

Who this might be right for
COVID-19Coronavirus 2019
National Human Genome Research Institute (NHGRI) 721
Not applicableStudy completedNCT06735300
What this trial is testing

Saliva PCR in Pregnant Women with COVID-19

Who this might be right for
Coronavirus Disease 2019 (COVID-19) Pneumonia
National Cheng-Kung University Hospital 37
Testing effectiveness (Phase 2)Study completedNCT04537949
What this trial is testing

A Trial Investigating the Safety and Effects of One BNT162 Vaccine Against COVID-19 in Healthy Adults

Who this might be right for
Covid-19Protection Against COVID-19
BioNTech SE 96
Testing effectiveness (Phase 2)WithdrawnNCT05545319
What this trial is testing

Learn About the Medicine Called Nirmatrelvir Used in Combination With Ritonavir in People With Weakened Immune Systems or at Increased Risk for Poor Outcomes Who Are Hospitalized Due to Severe COVID-19

Who this might be right for
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)Coronavirus Disease 2019 (COVID-19)Immunocompromised+2 more
Pfizer
Not applicableStudy completedNCT04339998
What this trial is testing

Assessment of Exam Findings in Coronavirus Disease 2019 (COVID-19) With Point-of-Care Ultrasonography (POCUS)

Who this might be right for
Coronavirus InfectionCOVIDCovid-19+1 more
University of Minnesota 129
Early research (Phase 1)Ended earlyNCT05075304
What this trial is testing

A Safety and Tolerability Study of BDB-001 in Mild, Moderate COVID-19 Patients

Who this might be right for
COVID-19
Staidson (Beijing) Biopharmaceuticals Co., Ltd 18
Not applicableStudy completedNCT04998799
What this trial is testing

Practice Variation on Antithrombotics in COVID-19

Who this might be right for
COVID-19 PneumoniaThrombosisCOVID-19 Acute Respiratory Distress Syndrome+1 more
NMC Specialty Hospital 435
Post-approval studies (Phase 4)Temporarily pausedNCT04334967
What this trial is testing

Hydroxychloroquine in Patients With Newly Diagnosed COVID-19 Compared to Standard of Care

Who this might be right for
COVID-19Corona Virus InfectionSARS-CoV-2+2 more
Providence Health & Services 13
Large-scale testing (Phase 3)UnknownNCT05091411
What this trial is testing

Clinical Trials of the Consistency and Non-inferiority Bridging Between Batches of Recombinant New Coronavirus Vaccine (CHO Cells)

Who this might be right for
Coronavirus Disease 2019
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 1,680
Not applicableStudy completedNCT04425213
What this trial is testing

Obesity and Mortality of Critically Ill Patients With COVID-19

Who this might be right for
COVIDSevere Acute Respiratory SyndromeObesity+1 more
Central Hospital, Nancy, France 250
Testing effectiveness (Phase 2)Study completedNCT04414618
What this trial is testing

Opaganib in Coronavirus Disease 2019 Pneumonia

Who this might be right for
Coronavirus Infections
RedHill Biopharma Limited 42
Testing effectiveness (Phase 2)WithdrawnNCT04536090
What this trial is testing

Study of Isoquercetin (IQC-950AN) Plus Standard of Care Versus Standard of Care Only for the Treatment of COVID-19

Who this might be right for
COVID-19
Institut de Recherches Cliniques de Montreal
Not applicableUnknownNCT05092568
What this trial is testing

Comparison of General Characteristics of Patients Diagnosed COVID-19 (Coronavirus )Positive Followed In Service

Who this might be right for
Coronavirus Disease 2019VacciniaSymptoms and Signs
Saglik Bilimleri Universitesi 45
Testing effectiveness (Phase 2)Looking for participantsNCT04896606
What this trial is testing

SARS-CoV-2 CTLS for Mild to Moderate COVID-19 Disease

Who this might be right for
Covid19
New York Medical College 50
Not applicableStudy completedNCT04357340
What this trial is testing

The Effects of Pulmonary Physiotherapy Treatments on Patients With COVID-19

Who this might be right for
Covid-19PneumoniaSARS Pneumonia
Tehran University of Medical Sciences 40
Testing effectiveness (Phase 2)Study completedNCT04914377
What this trial is testing

To Evaluate the Safety and Efficacy of TQ Formula in Covid-19 Participants

Who this might be right for
Covid19
Novatek Pharmaceuticals 55
Testing effectiveness (Phase 2)UnknownNCT04377334
What this trial is testing

Mesenchymal Stem Cells (MSCs) in Inflammation-Resolution Programs of Coronavirus Disease 2019 (COVID-19) Induced Acute Respiratory Distress Syndrome (ARDS)

Who this might be right for
ARDSCOVID-19
University Hospital Tuebingen 40
Large-scale testing (Phase 3)Study completedNCT05107375
What this trial is testing

Clinical Study of Recombinant Novel Coronavirus（COVID-19） Vaccine (CHO Cell) Combined With Influenza Vaccine

Who this might be right for
Coronavirus Disease 2019
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 299
Not applicableStudy completedNCT04760990
What this trial is testing

Assess the Potential Impact of Disease Modifying Therapies on COVID-19 Outcomes and the Antibody Response Following an Infection With SARS-CoV-2 in Patients With Multiple Sclerosis Within the Swiss Multiple Sclerosis Cohort.

Who this might be right for
Multiple SclerosisCOVID-19 (Severe Coronavirus Disease 2019)
University Hospital, Basel, Switzerland 1,181
Load More Results